Be part of the knowledge - ReachMD

Be part of the knowledge.™

Medical News

Medical News
Endoscopic Midface Rejuvenation Study Reports Improvements at 15 Months
10/02/2026

Popular

CME/CE In-Person & Virtual Event
From Fragmented Symptoms to Structured Care: Advancing Menopause Management in Primary Practice
October 19, 2026
Nashville, Tennessee
1.00 credits
Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
Dermatology Hub: Neuroimmune Network
Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
- Cheri Frey, MD
When Skin and Itch Do Not Match in Atopic Dermatitis
Dermatology Hub: Neuroimmune Network
When Skin and Itch Do Not Match in Atopic Dermatitis
- Elizabeth Swanson, MD, FAAD
ACACIA-HCM: What Do the Phase 3 Results Show?
Cardiology
ACACIA-HCM: What Do the Phase 3 Results Show?
- Ahmad Masri, MD, MS
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
- Komal Jhaveri, MD, FACP
0.50 program credits
Medical AI Needs Reasons, Not Just Answers
The Convergence
Medical AI Needs Reasons, Not Just Answers
- Brian P. McDonough, MD, FAAFP
- Michael Moor, MD, PhD

Programs

Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CE
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
- Dolores Shoback, MD
- Michael T. Collins, MD
0.75 credits
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Cardiology
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
- Erik Stroes
A New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
CME/CE
A New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
- Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
- Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
0.25 credits
Overcoming Challenges in Transthyretin Cardiac Amyloidosis
CME/CE
Overcoming Challenges in Transthyretin Cardiac Amyloidosis
- Mathew S. Maurer, MD
- Jan M. Griffin, MD
- Frederick Ruberg, MD
1.00 credits
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
MinuteCE®
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
- Natalie S. Callander, MD
0.75 program credits
Borderline Biomarkers: When a Blood Test Is Not Enough
MinuteCE®
Borderline Biomarkers: When a Blood Test Is Not Enough
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits

Clinical Practice

Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
CME/CE
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
- Carolyn Lam, MD, PhD
- Stephen J. Greene, MD
0.25 credits
CME/CE In-Person & Virtual Event
Unmasking HCM in Patients With Preserved EF: Diagnostic Clarity, Evolving Evidence, and Emerging Therapeutic Strategies
October 10, 2026
Multiple locations available
1.00 credits
Bridging the Bronchiectasis Gap: The Latest Emerging Multimodal Treatment Approaches
CME/CE
Bridging the Bronchiectasis Gap: The Latest Emerging Multimodal Treatment Approaches
- Ashley Losier, MD
- Ari Ciment, MD
- Laura Brenner, MD
1.00 credits
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
MinuteCE®
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
- Saad Z. Usmani, MD, MBA
- Natalie S. Callander, MD
0.75 program credits
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
MinuteCE®
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
- Saad Z. Usmani, MD, MBA
0.75 program credits
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
- Komal Jhaveri, MD, FACP
- Virginia Kaklamani, MD, DSc
0.50 program credits

Doctors Lounge

The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal Cancer
The Changing Landscape of CRC Screening and Prevention
- Ryan Quigley
- Samuel Muench, MD
The Promise and Peril of Clinical AI
The Convergence
The Promise and Peril of Clinical AI
- Brian P. McDonough, MD, FAAFP
- Raja-Elie E. Abdulnour, MD
- Jean-Claude Saghbini
Earlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
The Convergence
Earlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
- Brian P. McDonough, MD, FAAFP
- Adrian Noriega de la Colina, MD, PhD
- Arvid E. Gollwitzer
Engaging Patients and Caregivers About Digital Therapeutics
Medical Industry Feature
Engaging Patients and Caregivers About Digital Therapeutics
- Charles Turck, PharmD, BCPS, BCCCP
- Maggie Emerson, DNP, APRN, PMHNP-BC
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChats
Optimizing Medical Affairs Approaches with CME Best Practices
- Matt Birnholz, MD
- Karen Roy, MSc
Collaboration in Medical Affairs: Increasing Value and Impact
MAPSChats
Collaboration in Medical Affairs: Increasing Value and Impact
- Matt Birnholz, MD
- Renu Juneja, PhD

CME

Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CE
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
- Brian P. McDonough, MD, FAAFP
- Silvio Inzucchi, MD
- Jay H. Shubrook, DO, FACOFP, FAAFP
0.50 credits
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
MinuteCE®
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
- Saad Z. Usmani, MD, MBA
- Natalie S. Callander, MD
0.75 program credits
MinuteCE®
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
- Dani Cabral, MD
- David Weisman, MD
0.50 credits 6 episodes
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
MinuteCE®
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
- Virginia Kaklamani, MD, DSc
0.50 program credits
CME/CE In-Person & Virtual Event
Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona
1.00 credits
Antithrombotics and Amyloid Therapy: Balancing Risk
MinuteCE®
Antithrombotics and Amyloid Therapy: Balancing Risk
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits

Industry Feature

Single-Port Robotics Improves Outcomes for Thoracic Surgery
Medical Industry Feature
Single-Port Robotics Improves Outcomes for Thoracic Surgery
- Benjamin Lee, M.D.
- Jeffrey Port, M.D.
- Jonathan Villena-Vargas, M.D.
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry Feature
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
- Jennifer Caudle, DO, FACOFP
- Syma Iqbal, MD
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Innovations In Medicine
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
- Jennifer Caudle, DO, FACOFP
- Greg Mattingly, MD
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Innovations In Medicine
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew Freeman, MD, FACC, FACP
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Innovations In Medicine
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
- Charles Turck, PharmD, BCPS, BCCCP
- Joel L. Young, MD
Unraveling PMR Pathophysiology: The Central Role of IL-6
Medical Industry Feature
Unraveling PMR Pathophysiology: The Central Role of IL-6
- Charles Turck, PharmD, BCPS, BCCCP
- Adam Brown, MD
- Megan Sullivan, MD

Program Chapters

Segment Chapters

Playlist:

Recommended